| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0016-5085(99)70242-8 |
| P698 | PubMed publication ID | 9869616 |
| P2093 | author name string | Y Ueno | |
| H Francis | |||
| A Caligiuri | |||
| G Alpini | |||
| L Baiocchi | |||
| R Rodgers | |||
| G D LeSage | |||
| S S Glaser | |||
| J L Phinizy | |||
| L A Holcomb | |||
| P2860 | cites work | A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 |
| Production of bile duct hyperplasia and gallstones by lithocholic acid | Q34083152 | ||
| Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes. Role of ATP depletion and cytosolic free calcium | Q34109467 | ||
| Biliary physiology in rats with bile ductular cell hyperplasia. Evidence for a secretory function of proliferated bile ductules | Q35810064 | ||
| Increases of intracellular magnesium promote glycodeoxycholate-induced apoptosis in rat hepatocytes | Q35824326 | ||
| Rat cholangiocytes absorb bile acids at their apical domain via the ileal sodium-dependent bile acid transporter | Q37375465 | ||
| Histochemical and ultrastructural demonstration of gamma-glutamyl transpeptidase activity | Q48986289 | ||
| Effect of dietary chenodeoxycholic acid and lithocholic acid in the rabbit. | Q53724983 | ||
| Improved method for measuring the glycine and taurine conjugates of bile salts by high-performance liquid chromatography with tauro-7α,12α-dihydroxy-5β-cholanic acid as internal standard | Q57792246 | ||
| Feedback regulation of bile acid synthesis in the rat by dietary vs. intravenous cholate or taurocholate | Q68435493 | ||
| Effect of chronic administration of taurolithocholate on bile formation and liver ultrastructure in the rat | Q69155802 | ||
| Stimulatory effect of ursodeoxycholate on pancreatic exocrine secretion in an in vitro study | Q71703169 | ||
| Regrowth of the rat biliary tree after 70% partial hepatectomy is coupled to increased secretin-induced ductal secretion | Q71832692 | ||
| Functional expression of the apical Na+-dependent bile acid transporter in large but not small rat cholangiocytes | Q73835537 | ||
| A principle for counting tissue structures on random sections | Q76418947 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 179-186 | |
| P577 | publication date | 1999-01-01 | |
| P1433 | published in | Gastroenterology | Q4039279 |
| P1476 | title | Bile acid feeding induces cholangiocyte proliferation and secretion: evidence for bile acid-regulated ductal secretion | |
| P478 | volume | 116 |
| Q91940731 | Activation of WNT/Beta-Catenin Signaling and Regulation of the Farnesoid X Receptor/Beta-Catenin Complex After Murine Bile Duct Ligation |
| Q35201956 | Activation of muscarinic receptor signaling by bile acids: physiological and medical implications |
| Q33809704 | Alterations in xenobiotic metabolism in the long-lived Little mice |
| Q36506491 | Bile acid interactions with cholangiocytes |
| Q28084989 | Bile acid signaling and biliary functions |
| Q37157813 | Bile-acid-induced cell injury and protection |
| Q35087918 | Ca2+-dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts |
| Q36506477 | Cholangiocyte anion exchange and biliary bicarbonate excretion |
| Q35498362 | Cholangiocyte bile salt transporters in cholesterol gallstone-susceptible and resistant inbred mouse strains |
| Q37175438 | Cholangiocyte proliferation and liver fibrosis. |
| Q37067699 | Control of cholangiocyte adaptive responses by visceral hormones and neuropeptides |
| Q96230908 | Deoxycholic acid modulates the progression of gallbladder cancer through N6-methyladenosine-dependent microRNA maturation |
| Q40677743 | Effects of bile acids on biliary epithelial cells: proliferation, cytotoxicity, and cytokine secretion |
| Q34188025 | Effects of feeding bile acids and a bile acid sequestrant on hepatic bile acid composition in mice |
| Q37287593 | Endocrine and paracrine role of bile acids |
| Q73279207 | Gastrin reverses established cholangiocyte proliferation and enhanced secretin-stimulated ductal secretion of BDL rats by activation of apoptosis through increased expression of Ca2+- dependent PKC isoforms |
| Q33866793 | Heterogeneity of the intrahepatic biliary epithelium |
| Q38196813 | Histamine and histamine receptor regulation of gastrointestinal cancers |
| Q33909909 | Histamine regulation of hyperplastic and neoplastic cell growth in cholangiocytes |
| Q34029126 | Immunohistochemical study for the origin of ductular reaction in chronic liver disease |
| Q51989128 | Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis. |
| Q93112129 | Inflammation and Cell Death During Cholestasis: The Evolving Role of Bile Acids |
| Q36312676 | Insignificant effect of secretin in rodent models of polycystic kidney and liver disease |
| Q34992326 | Involvement of cholangiocyte proliferation in biliary fibrosis |
| Q40332260 | Lack of evidence that bone marrow cells contribute to cholangiocyte repopulation during experimental cholestatic ductal hyperplasia |
| Q35615198 | Lipopolysaccharide (LPS)-Induced Biliary Epithelial Cell NRas Activation Requires Epidermal Growth Factor Receptor (EGFR). |
| Q57057500 | Loss of hepatocyte β-Catenin protects mice from experimental porphyria-associated liver injury |
| Q39281829 | Mechanisms of Biliary Damage |
| Q38038172 | Mechanisms of Biliary Damage |
| Q39397552 | Mechanisms of cholangiocyte responses to injury |
| Q34528218 | Metabolic profiling of bile in cholangiocarcinoma using in vitro magnetic resonance spectroscopy |
| Q48223189 | Mitochondrial Mutations in Cholestatic Liver Disease with Biliary Atresia. |
| Q37142524 | Morphological and functional heterogeneity of the mouse intrahepatic biliary epithelium |
| Q37085046 | Multiple actions of secretin in the human body |
| Q33866778 | Nervous and Neuroendocrine regulation of the pathophysiology of cholestasis and of biliary carcinogenesis |
| Q37299662 | Non invasive high resolution in vivo imaging of alpha-naphthylisothiocyanate (ANIT) induced hepatobiliary toxicity in STII medaka |
| Q39440062 | Pathobiology of biliary epithelia. |
| Q38906942 | Pathogenesis of Kupffer Cells in Cholestatic Liver Injury |
| Q33949172 | Polycystic liver diseases. |
| Q28582467 | Prolactin stimulates the proliferation of normal female cholangiocytes by differential regulation of Ca2+-dependent PKC isoforms |
| Q48043487 | Qualitative metabolomics profiling of serum and bile from dogs with gallbladder mucocele formation. |
| Q33718790 | Recent advances in the regulation of cholangiocyte proliferation and function during extrahepatic cholestasis |
| Q34358007 | Recent advances on the mechanisms regulating cholangiocyte proliferation and the significance of the neuroendocrine regulation of cholangiocyte pathophysiology |
| Q34010481 | Regulation and deregulation of cholangiocyte proliferation |
| Q34755613 | Regulation of biliary proliferation by neuroendocrine factors: implications for the pathogenesis of cholestatic liver diseases |
| Q34229378 | Regulation of cholangiocyte proliferation |
| Q33863341 | Regulators of Cholangiocyte Proliferation |
| Q34121118 | Regulatory mechanisms of ductal bile secretion |
| Q34276575 | Role of cholangiocytes in primary biliary cirrhosis |
| Q35765708 | Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice |
| Q38764445 | TGR5 contributes to hepatic cystogenesis in rodents with polycystic liver diseases through cyclic adenosine monophosphate/Gαs signaling |
| Q38241386 | TGR5: pathogenetic role and/or therapeutic target in fibrosing cholangitis? |
| Q33750719 | Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas |
| Q37157705 | Taurocholate feeding to bile duct ligated rats prevents caffeic acid-induced bile duct damage by changes in cholangiocyte VEGF expression. |
| Q33936280 | Taurocholic acid prevents biliary damage induced by hepatic artery ligation in cholestatic rats. |
| Q44290863 | Taurohyodeoxycholate- and tauroursodeoxycholate-induced hypercholeresis is augmented in bile duct ligated rats |
| Q98185020 | The Functional Role of the Secretin/Secretin Receptor Signaling During Cholestatic Liver Injury |
| Q44835576 | Ursodeoxycholate further increases bile-duct cell proliferative response induced by partial bile-duct ligation in rats |
| Q57111050 | Ursodeoxycholate inhibits mast cell activation and reverses biliary injury and fibrosis in Mdr2 mice and human primary sclerosing cholangitis |
| Q38323349 | VPAC1 expression is regulated by FXR agonists in the human gallbladder epithelium |
| Q38252904 | Women and primary biliary cirrhosis |
| Q50887090 | β-Catenin regulation of farnesoid X receptor signaling and bile acid metabolism during murine cholestasis. |
Search more.